Basel, 30 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Johannes (Hans) Clevers (1957), M.D., Ph.D., Head of Roche Pharma Research and Early Development (pRED) and member of the ...

Guy Parmelin, Federal Counsel and Head of the Federal Department of Economic Affairs, Education and Research (EAER) will attend the center's inauguration Basel, 10 September 2024 - Roche (SIX: RO, ROG ...

Roche announced the opening of its new Pharma Research and Early Development (pRED) Centre at its global headquarters in Basel, Switzerland. Equipped with cutting-edge technologies and housing around ...

Herzog & de Meuron have a long history of collaboration with Roche, one of the world's largest pharmaceutical companies. (Julien Lanoo) Herzog & de Meuron (HdM) has designed a new research facility ...

John Reed's Basel-based pRED group at Roche has struck its first epigenetics deal, snapping up rights to Barcelona-based Oryzon's orphan cancer blocker ORY-1001, now being studied in the clinic for ...

They're building a new home for John Reed and Roche's ($RHHBY) pRED research group in Basel--and the pharma giant is thinking big. Roche said today that it is ...

Switzerland's most innovative research and development center underscores Roche's long-term investment in scientific advancement to meet patient needs The new center will simplify and increase ...

Basel, 17 February 2026 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Mark Dawson, M.D., Ph.D., as the new Head of Roche Pharma Research and Early Development (pRED), ...